GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haleon PLC (LSE:HLN) » Definitions » Accounts Payable & Accrued Expense

Haleon (LSE:HLN) Accounts Payable & Accrued Expense : £0 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Haleon Accounts Payable & Accrued Expense?

Haleon's quarterly accounts payable & accrued expense increased from Sep. 2023 (£0 Mil) to Dec. 2023 (£3,428 Mil) but then declined from Dec. 2023 (£3,428 Mil) to Mar. 2024 (£0 Mil).

Haleon's annual accounts payable & accrued expense increased from Dec. 2021 (£2,956 Mil) to Dec. 2022 (£3,414 Mil) and increased from Dec. 2022 (£3,414 Mil) to Dec. 2023 (£3,428 Mil).


Haleon Accounts Payable & Accrued Expense Historical Data

The historical data trend for Haleon's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haleon Accounts Payable & Accrued Expense Chart

Haleon Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Payable & Accrued Expense
2,791.00 2,775.00 2,956.00 3,414.00 3,428.00

Haleon Quarterly Data
Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 3,807.00 - 3,428.00 -

Haleon Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.


Haleon (LSE:HLN) Business Description

Industry
Traded in Other Exchanges
Address
The Heights, Building 5, First Floor, Surrey, Weybridge, GBR, KT13 0NY
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.